MyFinsight
Home
Blog
About
Contact
Download
Download image
Gross proceeds from
sale of common stock
$63K
Net cash provided by
financing activities
$61K
Effect of exchange rate
changes on cash
$1K
Canceled cashflow
$2K
Net decrease in cash
and cash...
-$1,207K
Canceled cashflow
$62K
Share-based compensation
$135K
Amortization of right-of-use
assets
$85K
Accounts receivable
-$64K
Accrued compensation
$63K
Depreciation and
amortization
$20K
Costs from sale of
common stock
$2K
Net cash used in
operating activities
-$1,250K
Canceled cashflow
$367K
Net cash used in
investing activities
-$19K
something is missing
$1,318K
Dividend, interest, and
other income (loss)
$1,174K
Net loss
-$1,312K
Canceled cashflow
$1,318K
Reduction in lease
liabilities
-$90K
Inventories
$84K
Provision for allowance
for credit losses
-$59K
Inventory reserve
-$36K
Prepaid expenses and
other
$24K
Accounts payable and
accrued expenses
-$12K
Expenditures related to
intangible assets
$19K
Total other income
(loss)
$1,174K
Net sales
$3,578K
Loss before income
taxes
-$2,613K
Canceled cashflow
$1,174K
(provision) benefit for
income taxes
$17K
Gross profit (loss)
$433K
Canceled cashflow
$3,145K
Loss from operations
-$3,787K
Canceled cashflow
$433K
Cost of sales
$3,145K
Total operating
expenses
$4,220K
General and
administrative
$2,353K
Sales and marketing
$1,284K
Research and development
$583K
Back
Back
Cash Flow
source: myfinsight.com
BIOMERICA INC (BMRA)
BIOMERICA INC (BMRA)